☰

Erdem Bangi, Ph.D. - Publications

Affiliations: 
2005 Brown University, Providence, RI 
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Teague AG, Quintero M, Karimi Dermani F, Cagan RL, Bangi E. A polycistronic transgene design for combinatorial genetic perturbations from a single transcript in Drosophila. Plos Genetics. 19: e1010792. PMID 37267433 DOI: 10.1371/journal.pgen.1010792  0.547
2023 Datta I, Vassel T, Linkous B, Odum T, Drew C, Taylor A, Bangi E. A targeted genetic modifier screen in Drosophila uncovers vulnerabilities in a genetically complex model of colon cancer. G3 (Bethesda, Md.). PMID 36880303 DOI: 10.1093/g3journal/jkad053  0.363
2021 Bangi E, Smibert P, Uzilov AV, Teague AG, Gopinath S, Antipin Y, Chen R, Hecht C, Gruszczynski N, Yon WJ, Malyshev D, Laspina D, Selkridge I, Wang H, Gomez J, et al. A Drosophila platform identifies a novel, personalized therapy for a patient with adenoid cystic carcinoma. Iscience. 24: 102212. PMID 33733072 DOI: 10.1016/j.isci.2021.102212  0.669
2020 Bangi E. Strategies for Functional Interrogation of Big Cancer Data Using Drosophila Cancer Models. International Journal of Molecular Sciences. 21. PMID 32466549 DOI: 10.3390/Ijms21113754  0.393
2020 Quintero M, Teague A, Cagan R, Bangi E. Abstract B11: Use of novel multigenic vectors to model complex genome-based colorectal cancer profiles in Drosophila Cancer Research. 80. DOI: 10.1158/1538-7445.Camodels2020-B11  0.628
2019 Bangi E. A Drosophila Based Cancer Drug Discovery Framework. Advances in Experimental Medicine and Biology. 1167: 237-248. PMID 31520359 DOI: 10.1007/978-3-030-23629-8_14  0.386
2019 Bangi E, Ang C, Smibert P, Uzilov AV, Teague AG, Antipin Y, Chen R, Hecht C, Gruszczynski N, Yon WJ, Malyshev D, Laspina D, Selkridge I, Rainey H, Moe AS, et al. A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer. Science Advances. 5: eaav6528. PMID 31131321 DOI: 10.1126/Sciadv.Aav6528  0.63
2016 Bangi E, Murgia C, Teague AG, Sansom OJ, Cagan RL. Functional exploration of colorectal cancer genomes using Drosophila. Nature Communications. 7: 13615. PMID 27897178 DOI: 10.1038/Ncomms13615  0.622
2016 Rozehnal JM, Posner MR, Ang C, Bangi E, Yeykal C, Cagan RL, Dang RP, Donovan M, Uzilov AV, Antipin Y, Schadt EE, Misiukiewicz K. Transgenic drosophila as a drug-screening platform in colorectal cancer and medullary thyroid cancer. Journal of Clinical Oncology. 34: e23164-e23164. DOI: 10.1200/Jco.2016.34.15_Suppl.E23164  0.636
2016 Rozehnal JM, Ang C, Donovan M, Bangi E, Yeykal C, Cagan RL, Antipin Y, Uzilov AV, Posner MR, Misiukiewicz K. Clinical outcomes in genetically targeted cancer treatment. Journal of Clinical Oncology. 34: e23127-e23127. DOI: 10.1200/Jco.2016.34.15_Suppl.E23127  0.575
2016 Bangi E, Murgia C, Teague A, Smibert P, Esernio J, Gruszczynski N, Yeykal C, Sansom O, Cagan R. Abstract 34: A Drosophila approach to personalized cancer therapeutics Clinical Cancer Research. 22: 34-34. DOI: 10.1158/1557-3265.Pmsclingen15-34  0.651
2015 Bangi E, Murgia C, Teague A, Sansom O, Cagan R. Abstract PR03: Identifying biomarkers of drug response and resistance using personalized Drosophila models of colorectal cancer Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-Pr03  0.637
2014 Rudrapatna VA, Bangi E, Cagan RL. A Jnk-Rho-Actin remodeling positive feedback network directs Src-driven invasion. Oncogene. 33: 2801-6. PMID 23831567 DOI: 10.1038/Onc.2013.232  0.717
2013 Bangi E. Drosophila at the intersection of infection, inflammation, and cancer. Frontiers in Cellular and Infection Microbiology. 3: 103. PMID 24392358 DOI: 10.3389/Fcimb.2013.00103  0.373
2013 Rudrapatna VA, Bangi E, Cagan RL. Caspase signalling in the absence of apoptosis drives Jnk-dependent invasion. Embo Reports. 14: 172-7. PMID 23306653 DOI: 10.1038/Embor.2012.217  0.703
2013 Bangi E, Murgia C, Teague A, Sansom O, Cagan R. Abstract B10: Modeling the complexity of colorectal tumors in Drosophila. Molecular Cancer Therapeutics. 12. DOI: 10.1158/1535-7163.Targ-13-B10  0.646
2012 Bangi E, Pitsouli C, Rahme LG, Cagan R, Apidianakis Y. Immune response to bacteria induces dissemination of Ras-activated Drosophila hindgut cells. Embo Reports. 13: 569-76. PMID 22498775 DOI: 10.1038/Embor.2012.44  0.591
2011 Bangi E, Garza D, Hild M. In vivo analysis of compound activity and mechanism of action using epistasis in Drosophila. Journal of Chemical Biology. 4: 55-68. PMID 22190992 DOI: 10.1007/S12154-010-0051-5  0.334
2009 Twombly V, Bangi E, Le V, Malnic B, Singer MA, Wharton KA. Functional analysis of saxophone, the Drosophila gene encoding the BMP type I receptor ortholog of human ALK1/ACVRL1 and ACVR1/ALK2. Genetics. 183: 563-79, 1SI-8SI. PMID 19620392 DOI: 10.1534/Genetics.109.105585  0.707
2009 Bangi E, Cagan RL. Abstract B34: Multigenic models of metastatic colon cancer inDrosophila Cancer Research. 69. DOI: 10.1158/0008-5472.Fbcr09-B34  0.466
2006 Bangi E, Wharton K. Dual function of the Drosophila Alk1/Alk2 ortholog Saxophone shapes the Bmp activity gradient in the wing imaginal disc. Development (Cambridge, England). 133: 3295-303. PMID 16887821 DOI: 10.1242/Dev.02513  0.702
2006 Bangi E, Wharton K. Dpp and Gbb exhibit different effective ranges in the establishment of the BMP activity gradient critical for Drosophila wing patterning. Developmental Biology. 295: 178-93. PMID 16643887 DOI: 10.1016/J.Ydbio.2006.03.021  0.695
Show low-probability matches.